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INTRODUCTION
Marker chromosomes are defined as unidentified structurally
abnormal chromosomes and their consequences may range
from being harmless to detrimental. Most of the marker chro-
mosomes are supernumerary marker chromosomes (SMCs)
that occur in addition to the 46 normal chromosomes and
sometimes as constituents of the 46 chromosomes by replac-
ing normal chromosomes. The latter is frequently found in
patients with Turner syndrome (TS). About 3% of TS patients
have a marker chromosome in addition to monosomy X (1).
Meanwhile, prevalence of SMCs at birth is estimated at 0.6-
1.5/1,000 (2, 3). About 80% of SMCs arise de novo and occur
more frequently with advanced maternal age (4). However,
there has been no study estimating the incidence of SMCs in
Korea.
Despite the importance of identifying the origin or com-
position of the marker chromosomes in genetic counseling,
they can rarely be defined with conventional cytogenetic tech-
niques alone. In recent years, the ascertainment of chromosome
origin has been made possible by the use of fluorescent in situ
hybridization (FISH) (5, 6). The use of FISH has rendered pos-
sible the delineation of genotype/phenotype correlations in
some cases. However, the application of all kinds of probes is
practically impossible due to high costs and limited specimens.
We conducted this study to investigate the incidences and
types of marker chromosomes in Korea and to establish a cost-
effective approach for identifying unknown marker chromo-
somes by FISH analysis.
MATERIALS AND METHODS
Chromosome analysis for constitutional abnormality was
performed on 2,984 patients (1,541 amniotic fluid specimens,
1,443 peripheral blood specimens) between 1997 and 2003
at the Samsung Medical Center. Ten patients with marker
chromosomes were found and studied.
Metaphase chromosome analysis of cultured amniocytes or
peripheral blood lymphocytes and GTG-staining were per-
formed using standard methods. Karyotypes were interpreted
according to the International System for Cytogenetic Nomen-
clature, 1995 (7).
FISH studies using probes D15Z1, D15S10, SNRPN,
TUPLE1, ARSA, SRY, and whole chromosome paint probes
(WCP) or chromosome enumeration probes (CEP) for X- and
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Marker Chromosomes in Korean Patients: Incidence, Identification
and Diagnostic Approach 
The identification of marker chromosomes is important for genetic counseling. How-
ever, the origin or composition can rarely be defined with conventional cytogenetic
technique alone. In this study, we investigated the incidences and types of marker
chromosomes in Korean patients and attempted to establish a cost-effective diag-
nostic approach for marker chromosomes. We reviewed the karyotypes of 2,984
patients that were requested for the cytogenetic analysis between 1997 and 2003
at the Samsung Medical Center. Ten marker chromosomes were found and iden-
tified using fluorescent in situ hybridization (FISH). Among the ten marker chromo-
somes, six were supernumerary marker chromosomes (SMCs) and the rest were
marker chromosomes in Turner syndrome (TS). The incidence of SMCs was 2.01/
1,000, slightly higher than that previously reported. Five of six SMCs were satellit-
ed marker chromosomes. Three bisatellited marker chromosomes originated from
chromosome 15 and two from chromosome 22. The origin of one SMC could not
be identified. All marker chromosomes in TS originated from X- or Y chromosome.
The application of FISH is indispensable to identify marker chromosomes, and the
appropriate selection of probes is necessary for cost-effective analysis. For analyz-
ing satellited marker chromosomes, application of probes for chromosome 15 fol-
lowed by those for chromosome 22 is recommended and in cases of TS, probes
for sex chromosomes should take precedence.
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Y chromosomes (Vysis Inc., Downers Grove, IL, U.S.A.) were
performed according to the manufacturer’ s instructions (Table
1). Additional studies for sex-determining region Y (SRY)
sequences were done using polymerase chain reaction (PCR)
in one case of TS.
The probes were hybridized to metaphase cells and the
images were captured with the Cytovision Image Analyzer
(Applied Imaging International Ltd., Newcastle, England).
In each analysis, the signals from the normal homologous
chromosomes served as internal controls and the marker was
scored positive only if the normal homologues and the marker
were labeled in at least five metaphases.
RESULTS
Incidence and identification of marker chromosomes
Marker chromosomes were observed in ten patients. Among
the ten marker chromosomes, six were SMCs and the rest were
marker chromosomes in TS. The incidence of SMCs in this
study was 2.01/1,000. The origins of the marker chromosomes
were identified in nine cases. In the remaining one case, no
signal was observed on FISH with the aforementioned battery
of probes. The markers were first categorized into two groups
according to the presence or absence of chromosomal satellites,
and later into three groups according to the FISH results. Five
of six SMCs were satellited marker chromosomes. Three bisatel-
lited marker chromosomes were found to be idic(15q) while
two satellited markers originated from chromosome 22. Two
of the three idic(15q) contained euchromatin including the
region responsible for Prader-Willi/Angelman syndrome (PWS/
AS) and both showed no deletion of the PWS/AS region in
normal homologous chromosome 15. Analysis for PWS/AS
region in the other idic(15q) case (case 1) could not be done
due to the insufficient amount of specimen. All marker chro-
mosomes in TS originated from the X- or Y chromosome: two
originated from X chromosome and the other two from Y
chromosome. One patient (case 7) with a marker originating
from the Y chromosome showed SRY sequence while two
patients with 45,X/46,X,mar(X) did not.
The inheritance status of the marker was ascertained in three *All probes are made by VYSIS (Vysis Inc., Downers Grove, IL, USA).
Chromosome Region Locus
15 Centromere D15Z1
15 15q11.2 SNRPN
15 15q11.2 D15S10
22 22q11.2 TUPLE1
22 22q13.3 ARSA
X Centromere DXZ1
X Whole chromosome -
Y Centromere DYZ1
Y Whole chromosome -
Y Yp11.3 SRY
Table 1. The panel of FISH probes* used to identify marker chro-
mosomes
Case
No.
Karyotype Age/Sex
Chr.
Origin
Morphology Size Parental Phenotype
A. Markers with satellites
1 47,XX,+mar.ish idic(15)(q13)(D15Z1++) 6 yr/F 15 bi-satellited ≤22 NE Developmental delay, tip-toeing gait, 
mental retardation, impaired speech, seizure
2 47,XX,+mar.ish idic(15)(q13)(D15Z1 ++, 5 yr/F 15 bi-satellited ≤22 NE Developmental delay, hyperactivity
D15S10++,SNRPN++)
3 47,XX,+mar.ish idic(15)(q13) 10 mo/F 15 bi-satellited ≤22 NE Developmental delay,
(D15Z1++,D15S10+) high-arched palate, microcephaly
4 47,XY,+mar.ish +del(22)(q13.1) 3 days/M 22 satellited <22 NE Imperforated anus, iris coloboma, 
(TUPLE1+,ARSA-) heart malformations
5 47,XX,+mar.ish +der(22)t(11;22) 15 days/F 22 satellited <22 maternal Intrauterine growth retardation, hypotonia,
(q23.3;q11.2)mat (TUPLE1+,ARSA-) preauricular tag, ptosis of left eye
B. Markers accompanied with monosomy X
6 45,X[3]/46,X,+mar.ish der(Y)(wcpY+)[7] 15 yr/F Y small ≤22 NE Short stature, no secondary sex characteristics
7 45,X[94]/46,X,+mar.ish der(Y) 18 yr/F Y small ≤22 NE Short stature, primary amenorrhea
(wcpY+,SRY+)[6]
8 45,X[4]/46,X,+mar.ish der(X) 26 yr/F X small ≤22 NE Primary amenorrhea, poor secondary
(wcpX+,SRY-)[6] sex characteristics
9 45,X[10]/46,X,+mar.ish der(X) 2 yr/F X small <22 de novo Developmental delay, poor feeding
(wcpX+,SRY-) [10]
C. Markers without satellites
10 47,XY,+mar.ish mar(D15Z1-,TUPLE-, 17
+2GA/M uniden- small <22 maternal Follow-up loss
wcpX-,wcpY-) mat[21]/46,XY[9] tified
Table 2. Summary of ten cases showing marker chromosomes
Chr, chromosomal; GA, gestational age; NE, not established.Marker Chromosomes in Korean Patients 775
cases. Two marker chromosomes were of maternal origin and
one was de novo. In case 5, the mother of the patient was a car-
rier of the unique, non-Robertsonian, reciprocal balanced
translocation t(11;22)(q23.3;q11.2). In case 10, the same
abnormal marker chromosome was found in a phenotypical-
ly normal mother. Table 2 shows the summary of the present
series and Fig. 1-3 reveals the morphology and FISH results
of the marker chromosomes.
Diagnostic approach to the marker chromosomes
The selection of probes was made on a case-by-case basis.
The first criterion of selection was the morphology of the mark-
er chromosomes observed on G-banding analysis. If there were
probable chromosomes derived from, the probes for those chro-
mosomes were applied first. The presence of satellites or accom-
Fig. 1. Routine and metaphase FISH analysis of the bisatellited SMC, idic(15)(q13). (A) GTG-banding of the SMC. (B) FISH analysis with the
D15S10 (red), D15ZI (green), and control PML (red) probes. Normal chromosome 15 homologues showed a signal for the D15ZI, D15S10,
and PML probes. SMC has two copies of D15S10 and D15ZI. (C) FISH analysis with the SNRPN (red), D15ZI (green), and control PML
(red) probes. SMC has also two copies of SNRPN and D15ZI. Arrows indicate SMCs. Images in the lower right box showed the magnified
marker chromosomes.
A B C
Fig. 3. Routine and FISH analysis of the marker chromosome accompanied with Turner syndrome. (A) GTG-banding of the SMC. (B)
Identification of the Y chromosomal material using metaphase FISH analysis with the probes for Y centromere (red) and X centromere
(green). Two red signals were observed. (C) Identification of the Y chromosomal material using interphase FISH analysis with the probe
for Y centromere (red).
A B C
X
Y
X
Y
Fig. 2. Routine and metaphase FISH analysis of the marker chro-
mosome accompanied with Turner syndrome. (A) GTG-banding of
the SMC. (B) Identification of the X chromosomal material using
metaphase FISH analysis with the whole chromosome paint probe
(wcp) X (green). Big arrow indicates the normal X chromosome
and small arrow indicates the marker chromosome.
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panied chromosome abnormalities was also important clues
for approach.
According to this study, we would like to recommend the
following. In patients with satellited marker chromosomes,
probes for chromosome 15 can be applied first followed by
probes for chromosome 22. If the origins of the markers could
not be identified by these probes, probes for other satellited
chromosomes could be considered in addition to testing the
probes for X- and Y chromosome. In cases with marker chro-
mosomes accompanied with monosomy X, probes for X- and
Y chromosome should be applied simultaneously first. If pos-
sible, parental studies should be done to determine inheritance
status.
DISCUSSION
The presence of a marker chromosome draws particular
attention in genetic counseling because it may be associated
with malformations and developmental abnormalities, although
it is also found in phenotypically normal individuals. If mark-
er chromosomes contain only the paracentromeric region and/
or satellites, and thus little or no euchromatic material, they
are considered to present lower risks of adverse clinical sequela
(1, 8). In any case, a detailed analysis of marker chromosomes
is mandatory for appropriate genetic counseling.
The incidence of SMCs in the present study was 2.01/1,000,
higher than 0.6-1.5/1,000 previously reported (2, 3). We pr-
esume the reason to be the selection bias. That is, the subjects
that were cytogenetically investigated here had been clinically
suspected as having constitutional chromosome abnormalities.
According to a study by Buckton et al. on a large popula-
tion, approximately 86% of the SMCs were derived from the
acrocentric chromosomes (2). However, Blennow et al. (9)
reported 5 of 37 SMCs of acrocentric origin containing no
satellite region. This result could have been an underestima-
tion considering only SMCs with satellites were recognized
cytogenetically. This observation underlines the need for FISH
in order to make a correct determination of the origin. In the
present study, 5/6 (83.3%) SMCs, a similar proportion to that
reported, were derived from the acrocentric chromosomes.
The most common SMCs are known to be SMCs originat-
ing from chromosome 15 (SMC(15)), in the form of inv dup
(15), constituting approximately half of the cases in popula-
tion studies (2). The present series also showed three (60%)
SMC(15)s among five acrocentric SMCs. The effect of the
SMC(15)s exerted upon the phenotype is determined by the
extent of the duplicated region and the parental origin (10).
SMC(15)s containing no euchromatin or only euchromatin
proximal to the PWS/AS region have been generally associated
with a normal phenotype (11, 12). In contrast, larger SMC(15)s
containing the PWS/AS region have been associated with a
wide spectrum of clinical features observed in PWS/AS, from
normal to full PWS/AS phenotype (13). However, even if
SMC(15)s contained the PWS/AS region, paternally-derived
SMC(15)s were associated with normal phenotype, while, in
contrast, maternally-derived SMC(15)s showed an abnormal
phenotype (13). All cases except case 1 showed larger SMC(15)s
containing the PWS/AS region. Furthermore, all showed
PWS/AS-like clinical features, but none met the diagnostic
criteria of PWS or AS. Although SMC(15)s were noted to
occur at a higher frequency in patients with PWS than in the
normal population, they lacked the PWS/AS region and the
symptoms were assumed to be caused by maternal uniparental
disomy (UPD) or loss of the PWS/AS region (14). So molec-
ular studies using methylation PCR to detect UPD or dele-
tion of the PWS/AS region should be considered in all SMC
(15) cases including familial cases inherited from a phenotyp-
ically normal carrier parent.
22q11.2 has been known as a very unstable region of chro-
mosome 22, which is involved in several syndromes related
to constitutional anomalies such as Cat eye syndrome (CES, a
trisomy or tetrasomy of 22q11), DiGeorge syndrome (a mi-
crodeletion), and supernumerary der(22)t(11;22) syndrome.
Similar to SMC(15)s, SMC(22)s containing additional copies
of proximal 22q euchromatin are associated with patients with
one or more of the malformations related to CES (15). How-
ever, there was no straightforward correlation between the
extent of additional copies found within the marker and the
severity of the CES phenotype. Case 4 had an extra satellited
monocentric chromosome 22 with terminal deletion at
22q13.1, trisomic of  “critical region” , 22pter-22q11. He show-
ed an imperforated anus, coloboma of the iris and heart
malformations, consistent with CES. Although colostomy had
been performed immediately after birth, he died nine days
thereafter. Case 5 had a SMC identified as a derivative chro-
mosome 22 from the unbalanced translocation between chro-
mosome 11 and 22 with breakpoints at 11q23.3 and 22q11.2,
respectively. The patient showed intrauterine growth retar-
dation, hypotonia, preauricular tag, and ptosis of the left eye,
which were consistent with supernumerary der (22) syndrome.
The clinical features of supernumerary der (22) syndrome are
the combined effects of partial trisomies for both 11q and
pericentromeric 22q (16).
Cases 6-9 were found to have mosaic 45,X/46,X,+mar. FISH
with wcp X and wcp Y confirmed the Y origin of the mark-
er chromosomes in cases 6 and 7 and the X origin in cases 8
and 9. Approximately 50% of patients with TS have either
various structural sex chromosome rearrangements or mosaics
with a variety of karyotypes and manifest the full or partial
Turner phenotype (17). Meanwhile, a Y chromosome or deriva-
tive of Y is present in 6% of the TS patients, and an addition-
al 3% have a marker chromosome that has been derived from
either the Y chromosome or some other chromosome (18).
The presence of Y chromosome sequences in TS patients mer-
its special attention because it predisposes the patients to devel-
oping gonadoblastoma and virilization with an estimated risk
of 15-25% (4, 19-21). Considering this potential risk, thescreening of all TS patients for the presence of Y sequences
has been previously suggested (4). Two of our cases were also
mosaic TS with Y chromosome sequences.
It has been reported that TS patients with 45,X/46,X,mar(X)
karyotypes may have unusually severe phenotypes, which
include mental retardation, soft tissue syndactyly, or abnor-
mal faces (22-24). Lack of the X inactivation center (XIC) at
Xq13.2 in these patients leads to functional disomy of the
proximal part of the X chromosome, which may have con-
tributed to the severe phenotypes observed in these patients
(23). We could not determine whether or not case 9 had men-
tal retardation due to her age. But case 8 with mar(X) did not
have mental retardation, and we can assume that her mar(X)
contained XIC, thus no functional disomy. Karyotyping for
more than 30 metaphases is mandatory in TS patients with
some degree of mental retardation to detect mar(X) chromo-
somes and, when detected, the parental origin and X inacti-
vation status of the chromosome should be subsequently de-
fined for accurate delineation of phenotype-genotype corre-
lation.
In case 10, we could not determine the origin of the SMC.
It may be assumed that the SMC ran in the patient’ s family
without association to phenotypic abnormalities because her
mother, who possessed the same marker chromosome, had a
normal phenotype. Additional FISH studies for chromosomes
other than chromosomes 15, 22, X, and Y would be needed
to establish the make-up of the SMC.
In conclusion, we could estimate the rough incidence of
SMCs in Korea. Satellited markers originating from chromo-
some 15 were most common. The molecular cytogenetic tech-
nique, FISH, accurately delineate the nature and origin of mar-
ker chromosomes, which is difficult by conventional cytoge-
netic procedures alone. In particular, the initial selection of
appropriate probes according to the morphology on G-band-
ing analysis is critical for cost-effective characterization. That
is, in cases with satellited marker chromosomes, probes for
chromosome 15 can be applied first followed by probes for
chromosome 22. If the origins of the markers could not be
identified by the above probes, the use of probes for other satel-
lited chromosomes in addition to X- and Y chromosomes
should be considered. For TS patients with marker chromo-
somes, beginning with probes for X- and Y chromosome is
preferable. Besides the identification of marker chromosomes,
clinical correlation, parental study, and consideration of other
possibilities are important in genetic counseling for patients
with marker chromosomes. 
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